Category: Diseases & Conditions
Global Diseases & Conditions
-
Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2024-2030
... was estimated at USD 499.78 million in 2023 and expected to reach USD 527.02 million in 2024, at a CAGR 5.71% to reach USD 737.69 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Disease type (Chlamydia, Genital herpes, Gonorrhea), Product Type, Settings, End-user - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 99.74 billion in 2024, at a CAGR 5.90% to reach USD 141.12 billion by 2030. Global STD Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Cancer Vaccines Market by Technology (Antigen, Dendritic Cells, Recombinant Cancer Vaccines), Treatment Method (Preventive Vaccine, Therapeutic Vaccine), Application - Global Forecast 2024-2030
... and expected to reach USD 20.56 billion in 2024, at a CAGR 15.37% to reach USD 48.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cancer Vaccines Market. ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Behavioral & Mental Health Software Market by Function (Administrative, Clinical, Financial), Category (Behavioral Therapy, IOP, Methadone Dosing), End-Users, Deployment - Global Forecast 2024-2030
... 3.19 billion in 2023 and expected to reach USD 3.49 billion in 2024, at a CAGR 9.45% to reach USD 6.01 billion by 2030. Global Behavioral & Mental Health Software Market FPNV Positioning Matrix The ... Read More
-
Cancer Biological Therapy Market by Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), Route of Administration (Intramuscular, Intravenous, Subcutaneous), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 72.42 billion in 2024, at a CAGR 11.60% to reach USD 140.04 billion by 2030. Global Cancer Biological Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030
... size was estimated at USD 9.31 billion in 2023 and expected to reach USD 9.98 billion in 2024, at a CAGR 7.48% to reach USD 15.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 80.88 million in 2024, at a CAGR 25.78% to reach USD 320.66 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Malaria Vaccine ... Read More
-
Gaucher Disease Treatment Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3), Treatment (Enzyme Replacement Therapy, Substrate Reduction Therapy), Diagnosis, Distribution Channel - Global Forecast 2024-2030
... Treatment Market size was estimated at USD 1.26 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 5.18% to reach USD 1.80 billion by 2030. FPNV Positioning Matrix The ... Read More
-
Insomnia Drugs Market by Type (Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants), Distribution Channels (Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 3.07 billion in 2024, at a CAGR 5.67% to reach USD 4.30 billion by 2030. Global Insomnia Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Insomnia Drugs ... Read More
-
Insomnia Pharmacological Treatment Market by Drug (OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements), Treatment (Over-the-Counter Sleep Aids, Prescription Sleep Aids), Distribution Channel - Global Forecast 2024-2030
... at USD 6.58 billion in 2023 and expected to reach USD 7.01 billion in 2024, at a CAGR 7.07% to reach USD 10.62 billion by 2030. Global Insomnia Pharmacological Treatment Market FPNV Positioning Matrix The ... Read More
-
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030
... at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024, at a CAGR 25.34% to reach USD 54.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
COVID-19 Testing Market by Kit Type (Rapid Test Kit, Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)), Test Type (Multiplex NAATs, NAAT Point of Care, Singleplex Nucleic Acid Amplification Tests), Specimen Type, Application - Global Forecast 2024-2030
... 2024-2030 The COVID-19 Testing Market size was estimated at USD 38.84 billion in 2023 and expected to reach USD 42.62 billion in 2024, at a CAGR 10.20% to reach USD 76.69 billion by 2030. Global ... Read More
-
Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030
... reach USD 80.62 billion in 2024, at a CAGR 19.72% to reach USD 237.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-Injectors Market. It offers a comprehensive ... Read More
-
Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 21.91 billion in 2024, at a CAGR 7.80% to reach USD 34.48 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Global Forecast 2024-2030
... 2023 and expected to reach USD 943.11 million in 2024, at a CAGR 39.62% to reach USD 7,011.84 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the HIV Vaccines ... Read More
-
Neonatal Critical Care Equipment Market by Product (Blood Pressure Monitors, Capnography, Cardiac Monitors), Type (Monitoring Equipment, Phototherapy Equipment, Respiratory Equipment), End-User - Global Forecast 2024-2030
... USD 1.14 billion in 2023 and expected to reach USD 1.24 billion in 2024, at a CAGR 8.28% to reach USD 2.00 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Global Forecast 2024-
... size was estimated at USD 3.53 billion in 2023 and expected to reach USD 3.71 billion in 2024, at a CAGR 5.48% to reach USD 5.13 billion by 2030.The hepatitis test solutions/ diagnosis are used ... Read More
-
Hemoglobinopathies Market by Indication (Sickle Cell Disease, Thalassemia), Treatment (Blood Transfusion, Bone Marrow & Stem Cell Transplant, Chemotherapy), Diagnosis, End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.79 billion in 2024, at a CAGR 33.02% to reach USD 19.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hemoglobinopathies Market. ... Read More
-
Hepatitis Therapeutics Market by Type (Hepatitis A, Hepatitis B, Hepatitis C), Drug Class (Immune Modulator, Oral Antiviral), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 30.76 billion in 2024, at a CAGR 4.11% to reach USD 38.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hepatitis Therapeutics ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2024-2030
... 2023 and expected to reach USD 49.91 billion in 2024, at a CAGR 23.31% to reach USD 176.48 billion by 2030. Global Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Nutrigenomics Market by Product (Reagents & Kits, Services), Application (Cancer, Cardiovascular Diseases, Obesity) - Global Forecast 2024-2030
... million in 2024, at a CAGR 17.53% to reach USD 1,887.63 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Nutrigenomics Market. It offers a comprehensive assessment of vendors, ... Read More
-
Erythropoietin Stimulating Agents Market by Type (Darbepoetin Alfa, Epoetin Alfa, Epoetin Beta), Application (Anemia, Antiretroviral Treatment, Cancer Chemotherapy) - Global Forecast 2024-2030
... 2023 and expected to reach USD 10.32 billion in 2024, at a CAGR 5.64% to reach USD 14.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Erythropoietin Stimulating ... Read More
-
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030. Global Brain Biomarkers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2024-2030
... Discovery Outsourcing Market size was estimated at USD 1.60 billion in 2023 and expected to reach USD 1.84 billion in 2024, at a CAGR 15.59% to reach USD 4.41 billion by 2030. Global Cancer Immunotherapy ... Read More
Research Assistance
